Cadila Healthcare has informed that it has enclosed a copy of press release dated June 14, 2021 titled ‘Zydus Cadila receives tentative approval from USFDA for Brivaracetam Tablets’. Bring this news to the notice of the members of the exchange and the investors’ at large.
The above information is a part of company’s filings submitted to BSE.